McGuire Investment Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,546
Closed -$113K 114
2025
Q1
$113K Sell
3,546
-10,981
-76% -$417K 0.02% 111
2024
Q4
$564K Buy
14,527
+485
+3% +$20.4K 0.08% 78
2024
Q3
$632K Sell
14,042
-420
-3% -$18.8K 0.09% 78
2024
Q2
$604K Sell
14,462
-201
-1% -$8.4K 0.09% 77
2024
Q1
$667K Buy
14,663
+924
+7% +$42.1K 0.1% 78
2023
Q4
$635K Sell
13,739
-2,296
-14% -$93.6K 0.11% 75
2023
Q3
$652K Sell
16,035
-1,955
-11% -$89K 0.13% 71
2023
Q2
$872K Sell
17,990
-5,080
-22% -$254K 0.16% 68
2023
Q1
$1.14M Sell
23,070
-39,479
-63% -$2.03M 0.23% 63
2022
Q4
$3.16M Sell
62,549
-66,509
-52% -$3.43M 0.68% 42
2022
Q3
$6.48M Sell
129,058
-2,414
-2% -$136K 1.48% 29
2022
Q2
$6.43M Buy
131,472
+475
+0.4% +$24.1K 1.38% 30
2022
Q1
$7.88M Buy
130,997
+23,272
+22% +$1.47M 1.44% 29
2021
Q4
$8.55M Buy
107,725
+22,268
+26% +$1.87M 1.41% 28
2021
Q3
$7.57M Buy
85,457
+18,981
+29% +$1.78M 1.42% 31
2021
Q2
$6.62M Sell
66,476
-307
-0.5% -$27.2K 1.26% 34
2021
Q1
$6M Buy
+66,783
New +$6.59M 1.27% 33

Other funds holding GNOM

McGuire Investment Group's GNOM Position: Q2 2025 in Review

McGuire Investment Group sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2025, closing a stake of 3,546 shares — an estimated $113K sold.

McGuire Investment Group first reported a position in GNOM in Q1 2021 and held it in 17 quarters. The position peaked at $8.55M in Q4 2021. 51 funds tracked by Wall St. Rank hold GNOM as of Q2 2025.

  • McGuire Investment Group reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • McGuire Investment Group sold 3,546 Global X Genomics & Biotechnology ETF shares in Q2 2025, an estimated $113K.
  • McGuire Investment Group first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and held it in 17 quarters.
  • McGuire Investment Group's Global X Genomics & Biotechnology ETF position peaked at $8.55M in Q4 2021.
  • 51 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2025.

Based on McGuire Investment Group's 13F filing for Q2 2025, filed 18 Jul 2025.